Andy Lynn is a board-certified toxicologist with over 20 years of experience in nonclinical sciences, specializing in toxicology strategy and operations within the biotech sector. Currently self-employed as an independent consultant, they design and monitor nonclinical studies for emerging biotech companies following their tenure at Moderna. In addition to their professional pursuits, Andy has been restoring a historic home in Bath, ME, and enjoys long-distance hiking. They hold an MBA from the University of Massachusetts at Amherst and a Master's in Pharmacology and Toxicology from Michigan State University. Andy is eager to transition back to an in-house role in the Greater Boston area, where they can actively contribute to therapeutic development.
This person is not in any teams
This person is not in any offices